GlassScriptPhysician profile
Alexander W Sobel
NPI 1992913917
$8,929.86
in general payments reported to CMS, 2019-2025
5 companies · $6,967 in 2025
The $6,967 reported for 2025 was more than what 96% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $161 · 2021: $14.50 · 2022: $615 · 2023: $470 · 2024: $252 · 2025: $6,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $2,667 · Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $2,667.09 |
| Food and Beverage | $1,271.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,956.41 | 2022-2025 | Biologics Consumables Autologous Cellular Products Adipose |
| Allergan, INC. | $830.26 | 2019-2022 | |
| Abbvie INC. | $708.23 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Summit Surgical Corp. | $311.36 | 2022 | |
| Coopersurgical, INC. | $123.60 | 2023 | Wallach Cryosurgical Equipment |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.